- Division of Basic and Integrative Biological Sciences – DBIB
- Review Branch:
- Molecular and Cellular Sciences and Technologies – MCST
- Study Section:
- Small Business: SBIR/STTR Commercialization Readiness Pilot (CRP) Program – MCST (19)
Dr. Allen Richon received his Ph.D. in organic chemistry at The University of North Carolina at Chapel Hill where his research focused on the synthesis of optically active natural products. Subsequently, he completed postdoctoral training in the synthesis of complex natural products at Stanford University. He then began his career in drug discovery and development at Ciba-Geigy Pharmaceuticals, where he was a medicinal and computational chemist with research interests in cardiovascular and metabolic diseases. He also led the development of research information systems as a senior manager at Ciba-Geigy and subsequently at Glaxo Pharmaceuticals. Dr. Richon also held positions at Tripos Associates, where he served as the director of training and consulting, MetaPhore Pharmaceuticals, where he served as the company’s business development officer, and LeadScope, Inc., where he was the Chief Executive Officer. Prior to joining CSR, he was the owner of an independent pharmaceutical R&D consulting and business development firm. During his tenure at CSR, Dr. Richon has organized and managed the review of a wide range of grant mechanisms including Research Centers, Data/Organizational Hubs, Program Projects, Shared Instrumentation, Fellowships/Training, Small Business, Research Facilities, International mHealth and other special RFAs.